Clinical Trials List
Protocol NumberBAY 86-9766 / 16553
2013-09-01 - 2017-05-31
Phase II
Terminated2
-
Trial Applicant
BAYER TAIWAN COMPANY LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Shang-Yin Wu Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 邱世賢 Digestive System Department
- Jing-Houng Wang Digestive System Department
- 周業彬 Digestive System Department
- 張國欽 Digestive System Department
- 郭垣宏 Digestive System Department
- 王心明 Digestive System Department
- 胡琮輝 Digestive System Department
- 郭仲謀 Digestive System Department
- 吳耿良 Digestive System Department
- 紀廣明 Digestive System Department
- 林明宗 Digestive System Department
- 蔡成枝 Digestive System Department
- 郭仲煌 Digestive System Department
- 邱逸群 Digestive System Department
- 陳建宏 Digestive System Department
- 顏毅豪 Digestive System Department
- 盧龍生 Digestive System Department
- 楊世正 Digestive System Department
- 趙景華 Digestive System Department
- 洪肇宏 Digestive System Department
- 曾柏霖 Digestive System Department
- 戴維震 Digestive System Department
- 梁志明 Digestive System Department
- 李全膜 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
100 participants
-
Global
2650 participants
